Clinical significance of peripheral blood UL16 and DR-70 for the early diagnosis and prognostic evaluation of colorectal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=63

Publishing Process of This Article

Item

Count

Browse

Download

Sum=11

Sep 15, 2024 (publication date) through Sep 10, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3832-3838
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3832

Table 2 Comparison of serum UL16-binding protein 2 and DR-70 levels among patients with different prognostic outcomes, mean ± SD

ULBP2: UL16-binding protein 2.

Citation: Zong ZP, Wu C. Clinical significance of peripheral blood UL16 and DR-70 for the early diagnosis and prognostic evaluation of colorectal cancer. World J Gastrointest Oncol 2024; 16(9): 3832-3838
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3832.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3832